Nasdaq

TMO Receives FDA Approval for Oncomine Dx Target Test

Thermo Fisher Scientific TMO recently received approval from the Food and Drug Administration (“FDA”) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be ...
RMD Open

Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...
ascopubs.org

Trends and disparities in cancer mortality among adults with psychoactive drug use disorders in United States, 1999–2023.

NGS-based DPYD diplotype analysis beyond conventional targeted variant testing in an ethnically diverse cancer patient cohort. Deaths and Age-adjusted Mortality Rates (AAMRs) per 100,000 for trends ...
ascopubs.org

Association of circulating tumor DNA (ctDNA) variant allelic frequency (VAF) with outcomes on matched targeted therapies (TT) in advanced non-small cell lung cancer (aNSCLC).

Osimertinib plus anlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer with concurrent gene alterations: A single-arm, prospective, multicenter phase II study. Safety ...
Healio

‘Start testing now’: Genetic variants greatly impact chemotherapy toxicity for GI cancers

Please provide your email address to receive an email when new articles are posted on . Genetic testing can be accomplished for most patients with gastrointestinal cancer prior to starting ...